Skip to main content

Table 2 Factors associated with positive attitude towards PrEP prescription among HIV specialists

From: Attitude towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among HIV specialists

  Attitude towards PrEP prescription Total (N = 311) Odds-ratio for positive attitude towards PrEP prescription
Positive (N = 216) Negative (N = 95)
N (%) N (%) N (%) OR (95% CI) MLR-OR (95% CI)
Demographic characteristics and work history
Gender
  Male 122 (56.5) 52 (54.7) 174 (55.9) 1 1
  Female 94 (43.5) 43 (45.3) 137 (44.1) 0.93 (0.57-1.51) 0.85 (0.50-1.45)
Age Class
  ≤40 33 (15.3) 18 (18.9) 51 (16.4) 1 1
  41-50 51 (23.6) 26 (27.4) 77 (24.8) 1.07 (0.51-2.25) 0.68 (0.30-1.56)
  >50 132 (61.1) 51 (53.7) 183 (58.8) 1.41 (0.73-2.73) 1.07 (0.51-2.25)
Length of service (years)
  < 10 35 (16.2) 20 (21.1) 55 (17.7) 1  
  10-19 71 (32.9) 35 (36.8) 106 (34.1) 1.16 (0.59-2.29)  
  > = 20 110 (50.9) 40 (42.1) 150 (48.2) 1.57 (0.81-3.03)  
Workplace
  Non teaching hospital 129 (59.7) 58 (61.1) 187 (60.1) 1  
  University/Research institute 87 (40.3) 37 (38.9) 124(39.9) 1.06 (0.65-1.73)  
Prevailing activity
  Ward/Inpatients 116 (53.7) 53 (55.8) 169 (54.3) 1  
  Outpatient clinic/Day hospital 100 (46.3) 42 (44.2) 142 (45.7) 1.09 (0.67-1.77)  
Survey
  Online Survey 69 (31.9) 55 (57.9) 124 (39.9) 1 1
  Regional HIV education 147 (68.1) 40 (42.1) 187 (60.1) 2.93 (1.78-4.82) 3.25 (1.79-5.91)
Participants’ experience with HIV-infected patients
Onset of activity with HIV patients
  HAART era 57 (26.4) 34 (35.8) 91 (29.3) 1  
  Pre-HAART era 159 (73.6) 61 (64.2) 220 (70.7) 1.55 (0.93-2.61)  
HIV-infected persons currently followed
  < =5 45 (20.8) 19 (20.0) 64 (20.6) 1  
  6-50 61 (28.2) 28 (29.5) 89 (28.6) 0.92 (0.46-1.85)  
  >50 110 (50.9) 48 (50.5) 158 (50.8) 0.97 (0.51-1.82)  
HIV tests prescribed in the last month
  < =5 109 (50.5) 46 (48.4) 155 (49.8) 1  
  6-20 77 (35.6) 33 (34.7) 110 (35.4) 0.98 (0.58-1.68)  
  >20 30 (13.9) 16 (16.8) 46 (14.8) 0.79 (0.39-1.59)  
Practice
Antiretrovirals prescription to HIV negative individuals
  No 26 (12.0) 30 (31.6) 56 (18.0) 1 1
  Yes 190 (88.0) 65 (68.4) 255 (82.0) 3.37 (1.86-6.12) 2.43 (1.29-4.61)
Pre-emptive information on Post-Exposure Prophylaxis
  No 65 (30.1) 44 (46.3) 109 (35,0) 1 1
  Yes 151 (69.9) 51 (53.7) 202 (65,0) 2.00 (1.22-3.30) 1.72 (1.01-2.92)
Knowledge
Self-evaluation of PrEP knowledge
  Poor 73 (33.8) 27 (28.4) 100 (32.1) 1 1
  Sufficient 72 (33.3) 42 (44.2) 114 (36.7) 0.63 (0.35-1.14) 0.87 (0.46-1.66)
  Good 71 (32.9) 26 (27.4) 97 (31.2) 1.01 (0.54-1.90) 1.75 (0.82-3.74)
  1. PrEP, Pre-exposure prophylaxis; HAART, Highly Active Anti-Retroviral Treatment; OR, Odds ratio; MLR-OR, Multiple variable Logistic Regression – Odds Ratio; CI, Confidence Interval.
  2. Boldface = p < 0.05.